Sen. Tammy Baldwin, Congressional LGBTQ+ Equality Caucus, LGBTQ groups celebrate new FDA proposal
We need a plan emphasizing equity in vaccination, testing, treatment
In clinical trials, recipients who were HIV negative had an 83 percent immune response 28 days after one dose compared to 98 percent with two doses...
Testing, transmission, other issues addressed at event sponsored by Blade, DC Health
CDC has reported roughly 350 cases
Apretude approved by FDA in December
D.C.’s Whitman-Walker, L.A. LGBT Center working on study to ease restrictions
Manufactured as Apretude, it will be available to at-risk adults & adolescents who weigh at least 77 pounds & have tested negative for HIV
'Scientific evidence does not support these restrictions'
Anger and a noble cause aren’t enough to sustain a movement
